Arthrosamid 2.5% PAAG – The Human Equivalent
Arthrosamid is the 2.5% polyacrylamide hydrogel developed as a long-acting intra-articular injection for the treatment of osteoarthritis in humans. Arthrosamid® is a new type of treatment for knee osteoarthritis that…
Use of Arthramid Vet in Canine Intra-articular injections
Nupsala Learning Resources in the UK recently published a webinar on Canine Intra-articular Injection. Dr Karen Cook BA VetMB BSc (Hons) MRCVS presents an informative webinar on the injection technique…
UK Equine Case Series 341 Horses and 804 joints
A case series report following the treatment with 2.5% polyacrylamide hydrogel of 804 joints in 341 horses (average of 2.36 joints per horse). The treatments were carried out by three…
Clinical Safety of Arthramid Vet 2.5% PAAG Hydrogel
Multiple studies have now shown that 2.5% PAAG is safe for use in animals and humans. Both in vitro and in vivo studies have taken place, designed to generate data…
Arthramid Vet 2.5% PAAG Hydrogel- Efficacy Study
Intra-articular administration of a 2.5% polyacrylamide hydrogel (PAAG- Arthramid Vet) is shown to reduce or abolish lameness in distal interphalangeal (coffin) and metacarpo/ metatarso- phalangeal (fetlock) joints in horses undertaking…
Arthramid Vet 2.5% PAAG – Mechanism Of Action
The mechanism of action of 2.5% PAAG appears multifaceted. Osteoarthritis (OA) describes inflammation of a joint and occurs after single or repetitive episodes of trauma. The term incorporates synovitis, capsulitis,…
